CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-12 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −5,094 | $356.94 | $1.8M | 201,230 |
| 2025-08-12 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −8,434 | $357.93 | $3.0M | 192,796 |
| 2025-08-12 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −5,032 | $358.83 | $1.8M | 187,764 |
| 2025-08-12 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −600 | $359.81 | $216K | 187,164 |
| 2025-08-12 | FRIEDMAN PAUL A Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −43,605 | 129,172 | ||
| 2025-08-11 | Taub Rebecca Director | Option exercise 10b5-1 | +3,200 | $9.45 | $30K | 464,244 |
| 2025-08-11 | Taub Rebecca Director | Sale 10b5-1 | −2,980 | $350.18 | $1.0M | 461,264 |
| 2025-08-11 | Taub Rebecca Director | Sale 10b5-1 | −220 | $351.02 | $77K | 461,044 |
| 2025-08-11 | Taub Rebecca Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,200 | 43,263 | ||
| 2025-08-11 | FRIEDMAN PAUL A Director | Option exercise 10b5-1 | +3,203 | $9.45 | $30K | 190,367 |
| 2025-08-11 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −2,903 | $350.19 | $1.0M | 187,464 |
| 2025-08-11 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −300 | $351.04 | $105K | 187,164 |
| 2025-08-11 | FRIEDMAN PAUL A Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,203 | 172,777 | ||
| 2025-08-01 | Brennan Daniel J. Director | Grant or award | +967 | 967 | ||
| 2025-08-01 | Brennan Daniel J. Director | Grant or award · Stock Option (Right to Buy) | +1,705 | 1,705 | ||
| 2025-07-18 | Taub Rebecca Director | Option exercise 10b5-1 | +1,000 | $9.45 | $9K | 462,044 |
| 2025-07-18 | Taub Rebecca Director | Sale 10b5-1 | −1,000 | $350.01 | $350K | 461,044 |
| 2025-07-18 | Taub Rebecca Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,000 | 46,463 | ||
| 2025-07-18 | FRIEDMAN PAUL A Director | Option exercise 10b5-1 | +1,400 | $9.45 | $13K | 188,564 |
| 2025-07-18 | FRIEDMAN PAUL A Director | Sale 10b5-1 | −1,400 | $350.03 | $490K | 187,164 |
Page 20 of 82 · 1,629 trades